PMID- 37647847
OWN - NLM
STAT- MEDLINE
DCOM- 20231023
LR  - 20231106
IS  - 1879-0739 (Electronic)
IS  - 0271-5317 (Linking)
VI  - 118
DP  - 2023 Oct
TI  - Daily higher tea consumption is associated with a reduced risk of type 2 
      diabetes: A cohort study and updated systematic review and meta-analysis.
PG  - 116-127
LID - S0271-5317(23)00073-8 [pii]
LID - 10.1016/j.nutres.2023.08.002 [doi]
AB  - Tea is abundant in phytochemicals (such as polyphenols and theaflavins), which 
      have a hypoglycemic effect. Previous studies investigating the relationship 
      between tea consumption and the risk of type 2 diabetes mellitus (T2DM) have 
      yielded inconsistent results. We hypothesized that tea consumption would be 
      associated with a reduced risk of T2DM. This cohort study used data from the 
      China Health and Nutrition Survey, involving a total of 5199 participants 
      initially recruited in 1997 and subsequently followed until 2009. Consumption of 
      any variety of tea was tracked using structured questionnaires, and T2DM was 
      diagnosed according to the American Diabetes Association's criteria. We also 
      performed a systematic literature search of PubMed, Web of Science, and EMBASE 
      for publications through September 2021, including 19 cohort studies comprising 
      1,076,311 participants. In our cohort study, the logistic regression model showed 
      a relative risk (RR) of T2DM among tea drinkers of 1.02 (95% confidence interval 
      [CI], 0.82-1.28) compared with non-tea drinkers. Although our updated 
      meta-analysis showed no significant association between tea consumption and T2DM 
      on the whole (pooled RR of 0.96 [0.91-1.00]), compared with the non-tea-drinking 
      group, participants consuming 4 or more cups of tea per day had a 17% reduced 
      risk of T2DM, with an RR of 0.83 (95% CI, 0.76-0.90). These data support our 
      hypothesis that tea consumption at higher doses (e.g., >/=4 cups/day) is associated 
      with a reduced risk of T2DM.
CI  - Copyright (c) 2023 Elsevier Inc. All rights reserved.
FAU - Li, Xiaying
AU  - Li X
AD  - College of Medicine, Wuhan University of Science and Technology, Wuhan, Hubei, 
      China.
FAU - Zeng, Jingjing
AU  - Zeng J
AD  - Center for Clinical Evidence-Based and Translational Medicine, Xiangyang Central 
      Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, 
      Hubei, China.
FAU - Chen, Bo
AU  - Chen B
AD  - Center for Clinical Evidence-Based and Translational Medicine, Xiangyang Central 
      Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, 
      Hubei, China.
FAU - Yan, Qiongjie
AU  - Yan Q
AD  - Center for Clinical Evidence-Based and Translational Medicine, Xiangyang Central 
      Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, 
      Hubei, China.
FAU - Cui, Yuze
AU  - Cui Y
AD  - Center for Clinical Evidence-Based and Translational Medicine, Xiangyang Central 
      Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, 
      Hubei, China.
FAU - Xu, Wenlei
AU  - Xu W
AD  - Center for Clinical Evidence-Based and Translational Medicine, Xiangyang Central 
      Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, 
      Hubei, China.
FAU - Zhang, Xiaotong
AU  - Zhang X
AD  - Department of Nephrology, Xiangyang Central Hospital, Affiliated Hospital of 
      Hubei University of Arts and Science, Xiangyang, Hubei, China.
FAU - Xu, Shaoyong
AU  - Xu S
AD  - Center for Clinical Evidence-Based and Translational Medicine, Xiangyang Central 
      Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, 
      Hubei, China; Department of Endocrinology, Xiangyang Central Hospital Affiliated 
      Hospital of Hubei University of Arts and Science, Xiangyang, Hubei, China. 
      Electronic address: yoji_xu@hotmail.com.
LA  - eng
PT  - Journal Article
PT  - Meta-Analysis
PT  - Research Support, Non-U.S. Gov't
PT  - Systematic Review
DEP - 20230807
PL  - United States
TA  - Nutr Res
JT  - Nutrition research (New York, N.Y.)
JID - 8303331
RN  - 0 (Tea)
RN  - 0 (Polyphenols)
SB  - IM
MH  - Humans
MH  - *Diabetes Mellitus, Type 2/epidemiology/prevention & control
MH  - Cohort Studies
MH  - Tea
MH  - Risk
MH  - Polyphenols
MH  - Risk Factors
OTO - NOTNLM
OT  - China Health and Nutrition Survey
OT  - Cohort study
OT  - Meta-analysis
OT  - Tea consumption
OT  - Type 2 diabetes mellitus
COIS- Declaration of Competing Interest None
EDAT- 2023/08/31 00:41
MHDA- 2023/10/23 12:43
CRDT- 2023/08/30 18:09
PHST- 2023/04/11 00:00 [received]
PHST- 2023/07/31 00:00 [revised]
PHST- 2023/08/06 00:00 [accepted]
PHST- 2023/10/23 12:43 [medline]
PHST- 2023/08/31 00:41 [pubmed]
PHST- 2023/08/30 18:09 [entrez]
AID - S0271-5317(23)00073-8 [pii]
AID - 10.1016/j.nutres.2023.08.002 [doi]
PST - ppublish
SO  - Nutr Res. 2023 Oct;118:116-127. doi: 10.1016/j.nutres.2023.08.002. Epub 2023 Aug 
      7.